Monitor the use of proceeds for advancement of product candidates and potential M&A activity. The convertible notes offering closing the next day could impact capital structure and future dilution if converted.
Price Chart
Executive Summary
Revolution Medicines raised approximately $1.65 billion through a public offering of 12.15 million common shares at $142.00 per share, alongside a separate $500 million convertible note offering. The proceeds will fund R&D, commercialization of product candidates, and general corporate purposes.
Key Facts
- Company issued 12,147,887 shares of common stock (10,563,381 base + 1,584,506 option) at $142.00 per share
- Net proceeds from equity offering estimated at $1.65 billion after underwriting discounts and expenses
- Concurrent $500 million offering of 0.50% convertible senior notes due 2033
- Proceeds to be used for R&D, potential commercialization of product candidates, general corporate purposes, and potential acquisitions
- Equity offering closed on April 16, 2026; convertible note offering expected to close April 17, 2026
Financial Impact
Raised $1.65 billion from equity offering and $500 million from convertible notes, totaling $2.15 billion in gross proceeds
Risk Factors
- Dilution from issuance of new shares
- Future dilution if convertible notes are converted to equity
- Execution risk in R&D and commercialization efforts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-159289 |
| Document: d95226d8k.htm | 0001193125-26-159289 |
| Document: d95226dex51.htm | 0001193125-26-159289 |
| Document: 0001193125-26-159289-index-headers.html | 0001193125-26-159289 |
| Document: 0001193125-26-159289-index.html | 0001193125-26-159289 |
| Document: 0001193125-26-159289.txt | 0001193125-26-159289 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 17, 2026 24w ago | 8-K | $1.88 $9.07 | ▼ −382.45% | ▼ −375.67% | — |
Apr 16, 2026 24w ago | 8-K | $1.88 $8.98 | ▲ +377.66% | ▲ +371.52% | — |
Apr 15, 2026 24w ago | 424B5 | $1.88 $8.96 | ▲ +376.60% | ▲ +369.55% | — |
Apr 15, 2026 24w ago | 424B5 | $1.88 $8.96 | ▼ −376.60% | ▼ −369.55% | — |
Apr 15, 2026 24w ago | 144 | $1.88 $8.96 | ▼ −376.60% | ▼ −369.55% | — |
Apr 13, 2026 24w ago | 424B5 | $1.88 $9.82 | ▼ −422.13% | ▼ −413.61% | — |
Apr 13, 2026 24w ago | 424B5 | $1.88 $9.82 | ▼ −422.13% | ▼ −413.61% | — |
Apr 13, 2026 24w ago | 8-K | $1.88 $9.66 | ▲ +413.83% | ▲ +404.91% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access